The Future of theCancer Cachexia Market: Growth Trends, Market Size, and Opportunities to Watch
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the Cancer Immunotherapy Drug Discovery Outsourcing Market?
The escalation in the expenditure associated with research and development is predicted to fuel the cancer immunotherapy drug discovery outsourcing market’s expansion. The steep costs of R&D are primarily attributable to the required specialized knowledge, high-priced machinery, and the innate risks that come with innovation. By outsourcing drug discovery tasks, the benefits of the economies of scale provided by contract research organizations (CROs) can be utilized, allowing smaller biotech companies and startups to maximize their R&D budgets and distribute resources more judiciously, boosting cost-efficiency. For instance, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a trade body representing the pharmaceutical sector, reported in June 2023 that the total pharmaceutical R&D spending in Europe reached $49,500 million (€44,500 million) in 2022, marking an approximately 6.45% rise from $46,500 million (€42,533 million) in 2021. Consequently, the prohibitive costs associated with in-house research and development are propelling the growth of the cancer immunotherapy drug discovery outsourcing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15528&type=smp
#How Will the CAGR of the Cancer Immunotherapy Drug Discovery Outsourcing Market Influence Its Overall Growth by 2034?
The size of the market for cancer immunotherapy drug discovery outsourcing has seen significant expansion in the past few years. It’s projected to increase from $1.5 billion in 2024 to $1.68 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. The historic growth can be credited to a rise in adverse drug reaction cases, a surge in demand for comprehensive genomic testing, an amplified global occurrence of cancer, an escalating requirement for targeted therapy, and an increasing count of clinical trials.
Expectations are high for swift expansion in the cancer immunotherapy drug discovery outsourcing market over the following years, with predictions it will reach $2.57 billion by 2029, achieving a compound annual growth rate (CAGR) of 11.3%. Key driving forces during this period include an intensified focus on personalized treatments, boosted diagnostic testing, a growing emphasis on personalized cancer therapy, increased expenditure on healthcare, and heightened incidence and awareness of cancer. The period is also expected to be marked by significant developments in diagnostic technologies, the application of next-generation sequencing (NGS) and artificial intelligence (AI), advancements in liquid biopsy technologies, the creation of point-of-care companion diagnostic devices, and the introduction of inventive testing technologies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15528
What Are the Most Significant Market Trends Transforming theCancer Immunotherapy Drug Discovery Outsourcing Market?
Prominent entities in the cancer immunotherapy drug discovery outsourcing market are leveraging strategic alliances to facilitate the creation of cancer treatments and secure a market edge. A strategic alliance essentially means a cooperative venture between multiple organizations where they amalgamate their assets, skills, and efforts to accomplish mutual targets or objectives. For example, in February 2022, Ono Pharmaceutical Co., Ltd., a pharmaceutical company based in Japan, and Bristol-Myers Squibb, a biopharmaceutical company rooted in the US, formed an outsourcing contract with Prime Research Institute for Medical Research, Inc., a research institute originating from Japan. The partnership is aimed at a joint clinical research project centered around patients with gastric cancer treated with Opdivo (nivolumab) in conjunction with chemotherapy. This collaborative venture, sponsored by the industry, is a broad-based, multi-institutional study that employs PRiME-R’s data support system, namely CyberOncology, which aids in the standardization, structuring, management, and fusion of real-world data in regular cancer clinical treatment. The clinical research that uses CyberOncology, evaluates the effect of Opdivo when combined with chemotherapy for the cases of untreated advanced or recurring gastric cancer. Incorporating about 30 nationwide medical institutions, the research aims to simplify data input, improve data precision, and hasten the process of analysis.
What Are the Top Market Players Propelling the Growth of theCancer Immunotherapy Drug Discovery Outsourcing Industry?
Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the Cancer Immunotherapy Drug Discovery Outsourcing Market Are Driving Growth and Industry Transformations?
The cancer immunotherapy drug discovery outsourcing market covered in this report is segmented –
1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types
2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-Based Assays
3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas
Subsegments:
1) By Monoclonal Antibodies: Checkpoint Inhibitors, Therapeutic Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates (ADCs)
2) By Immunomodulators: Cytokines, Immune Checkpoint Modulators, Toll-Like Receptor Agonists, Immune Adjuvants
3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies, Cancer Vaccines, Viral Vectors For Immunotherapy
4) By Other Drug Types: Adoptive Cell Therapy, Immune Cell Modulators, Small Molecule Immune Modulators, Gene Editing And Immunotherapy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15528&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Cancer Immunotherapy Drug Discovery Outsourcing Market?# Market?
North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Cancer Immunotherapy Drug Discovery Outsourcing Market 2025, By The Business Research Company:
Breast Cancer Monoclonal Antibodies Global Market Report 2024
Bladder Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bladder-cancer-drugs-global-market-report
Blood Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-cancer-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
